Holen Sie sich die Stockscreener-App
10.37
0.68%
0.07
Handel nachbörslich:
10.37
Schlusskurs vom Vortag:
$10.30
Offen:
$10.469
24-Stunden-Volumen:
1,176
Relative Volume:
0.01
Marktkapitalisierung:
$205.15M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-0.38%
1M Leistung:
-0.58%
6M Leistung:
+3.65%
1J Leistung:
+0.00%
1-Tages-Spanne:
$10.37
$10.47
1-Wochen-Bereich:
$10.30
$10.47
52-Wochen-Spanne:
$9.95
$10.85
Oaktree Acquisition Corp Iii Life Sciences Stock (OACC) Company Profile
Firmenname
Oaktree Acquisition Corp Iii Life Sciences
Sektor
Branche
Telefon
213-830-6300
Adresse
333 SOUTH GRAND AVENUE, 28TH FLOOR, LOS ANGELES
Vergleichen Sie OACC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OACC
Oaktree Acquisition Corp Iii Life Sciences
|
10.37 | 253.20M | 0 | 0 | 0 | 0.00 |
|
LION
Lionsgate Studios Corp
|
6.30 | 1.81B | 3.13B | -174.20M | -111.20M | -0.6688 |
|
AACT
Ares Acquisition Corporation Ii
|
11.39 | 703.96M | 0 | 16.92M | -1.35M | 0.29 |
|
AAM
Aa Mission Acquisition Corp
|
10.46 | 459.53M | 0 | 0 | 0 | 0.00 |
|
CCCX
Churchill Capital Corp X
|
10.12 | 527.79M | 0 | 0 | 0 | 0.00 |
|
TACO
Berto Acquisition Corp
|
10.39 | 388.69M | 0 | 0 | 0 | 0.00 |
Oaktree Acquisition Corp Iii Life Sciences Aktie (OACC) Neueste Nachrichten
Does Oaktree Acquisition Corp. III Life Sciences Equity Warrant qualify in momentum factor screening2025 Historical Comparison & AI Forecasted Entry/Exit Points - Newser
What’s the recovery path for long term holders of Oaktree Acquisition Corp. III Life SciencesMarket Weekly Review & Reliable Volume Spike Trade Alerts - Newser
Can Oaktree Acquisition Corp. III Life Sciences recover in the next quarter2025 Biggest Moves & AI Forecast for Swing Trade Picks - Newser
Is TAVIU Forming a Bottom PatternJuly 2025 Spike Watch & Entry Point Confirmation Signals - newsimpact.co.kr
Will Voya Financial Inc. stock recover after recent drop2025 Dividend Review & Smart Allocation Stock Tips - Newser
Combining machine learning predictions for Oaktree Acquisition Corp. III Life SciencesBond Market & Technical Pattern Alert System - Newser
Measuring Oaktree Acquisition Corp. III Life Sciences’s beta against major indices2025 Growth vs Value & High Accuracy Buy Signal Tips - Newser
Why 180 Life Sciences Corp. Equity Warrant stock attracts strong analyst attentionEarnings Summary Report & Weekly Stock Performance Updates - Newser
Analyzing Oaktree Acquisition Corp. III Life Sciences with multi timeframe chartsQuarterly Trade Review & Daily Growth Stock Investment Tips - Newser
Kepos Capital LP Makes New Investment in Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) - MarketBeat
Backtesting results for ASND trading strategiesJuly 2025 Levels & Reliable Momentum Entry Alerts - Newser
Custom watchlist performance reports with Oaktree Acquisition Corp. III Life Sciences2025 AllTime Highs & Smart Allocation Stock Tips - Newser
Tools to assess Oaktree Acquisition Corp. III Life Sciences’s risk profilePortfolio Return Report & Accurate Buy Signal Notifications - Newser
Identifying reversal signals in Oaktree Acquisition Corp. III Life Sciences Equity WarrantWeekly Investment Recap & Fast Exit and Entry Strategy Plans - Newser
Visualizing Oaktree Acquisition Corp. III Life Sciences Equity Warrant stock with heatmapsPortfolio Risk Summary & Growth Focused Stock Reports - Newser
Has Oaktree Acquisition Corp. III Life Sciences Equity Warrant found a price floorPortfolio Risk Summary & Reliable Entry Point Trade Alerts - Newser
Using R and stats models for Oaktree Acquisition Corp. III Life Sciences forecastingWeekly Trend Recap & Technical Pattern Based Signals - Newser
Plum Acquisition Corp. IV stock daily chart insightsWeekly Stock Summary & Consistent Profit Trade Alerts - Newser
Published on: 2025-08-17 14:09:10 - Newser
Key resistance and support levels for CUBWWQuarterly Risk Review & Free Expert Approved Momentum Trade Ideas - Newser
Goldman Sachs Group Inc's Strategic Acquisition in Oaktree Acquisition Corp III Life Sciences - GuruFocus
Does WFRD fit your quant trading modelJuly 2025 Snapshot & Fast Moving Stock Watchlists - Newser
Candlestick signals on Grace Therapeutics Inc. stock todayTrend Reversal & Risk Adjusted Buy/Sell Alerts - Newser
Sectors Driving Future Growth for Oaktree Acquisition Corp. III Life Sciences StockMarket Performance Report & Technical Pattern Recognition Alerts - Newser
Applying Wyckoff theory to Oaktree Acquisition Corp. III Life Sciences Equity Warrant stock2025 Volatility Report & Fast Exit and Entry Trade Guides - Newser
Published on: 2025-08-16 23:04:27 - Newser
What machine learning models say about Oaktree Acquisition Corp. III Life SciencesQuarterly Profit Report & Reliable Trade Execution Plans - Newser
Is TD Capital Trust III Preferred Security reversing from oversold territoryMarket Volume Report & Weekly High Momentum Picks - Newser
Visual trend scoring systems applied to Honda Motor Co. Ltd. Depositary ReceiptJuly 2025 Patterns & Entry and Exit Point Strategies - Newser
Oaktree Acquisition Corp. III Life Sciences Equity Warrant Stock Approaches Key Moving AverageMarket Activity Report & AI Enhanced Execution Alerts - beatles.ru
Is EPY(emphy) a Good InvestmentProfit Target & Daily Technical Forecast Reports - Newser
Trend analysis for Oaktree Acquisition Corp. III Life Sciences this weekJuly 2025 Review & Free Safe Capital Growth Stock Tips - Newser
Advanced analytics toolkit walkthrough for Compass Minerals International Inc.2025 Volume Leaders & Weekly Momentum Picks - Newser
What technical models suggest about BEPC’s comebackQuarterly Performance Summary & Accurate Technical Buy Alerts - Newser
Real time scanner hits for Conduit Pharmaceuticals Inc. Equity Warrant explained2025 Institutional Moves & Weekly Watchlist for Consistent Profits - Newser
What makes Oaktree Acquisition Corp. III Life Sciences Equity Warrant stock price move sharplyStop Loss & Verified Stock Trade Ideas - Newser
Mizuho Securities USA LLC Acquires Shares of 200,000 Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) - MarketBeat
Candlestick signals on Oaktree Acquisition Corp. III Life Sciences Equity Warrant stock today2025 Trading Recap & Stock Portfolio Risk Control - Newser
How to use Fibonacci retracement on GFAI2025 Market Outlook & Long-Term Safe Return Strategies - Newser
Detecting support and resistance levels for Oaktree Acquisition Corp. III Life SciencesWeekly Profit Analysis & Weekly High Return Forecasts - Newser
Is ATYR building a consolidation baseCEO Change & Short-Term Trading Opportunity Alerts - Newser
Real time pattern detection on SATL stock2025 Volatility Report & Low Drawdown Trading Techniques - Newser
Can National Bankshares Inc. hit a new high this monthJuly 2025 Patterns & Verified Technical Signals - Newser
Can Oaktree Acquisition Corp. III Life Sciences hit a new high this month2025 Top Gainers & Real-Time Market Trend Scan - Newser
Is Oaktree Acquisition Corp. III Life Sciences Equity Warrant stock entering bullish territory2025 Winners & Losers & Technical Pattern Based Buy Signals - Newser
Company Inc. lead to full recovery2025 Short Interest & Consistent Profit Alerts - Newser
Is CMPS Stock a Smart Buy in 2025 Investment Analysis InsideBuy Signal & Precise Swing Trade Alerts - Newser
New Product Launches: Will They Boost TTM Technologies Inc. Stock in 2025Market Activity Recap & Scalable Portfolio Growth Ideas - Newser
Applying Elliott Wave Theory to Oaktree Acquisition Corp. III Life Sciences Equity WarrantJuly 2025 Outlook & Fast Entry and Exit Trade Plans - Newser
Oaktree Acquisition Corp. III Life Sciences stock outlook for YEAR2025 Technical Patterns & Free Expert Approved Momentum Trade Ideas - Newser
Automated trading signals detected on Oaktree Acquisition Corp. III Life Sciences Equity Warrant2025 Biggest Moves & Daily Risk Controlled Trade Plans - Newser
Finanzdaten der Oaktree Acquisition Corp Iii Life Sciences-Aktie (OACC)
Es liegen keine Finanzdaten für Oaktree Acquisition Corp Iii Life Sciences (OACC) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.00%
0.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):